Maternal-child dyad health outcomes: neurodevelopment at three years in the context of maternal cannabis use - an extension of a prospective cohort study

母婴二元健康结果：母亲使用大麻三年内的神经发育——前瞻性队列研究的延伸

• 批准号: 465631
• 负责人: Hicks Matthew S
• 金额: $ 36.43万
• 依托单位: University of Alberta
• 依托单位国家: 加拿大
• 项目类别: Operating Grants
• 财政年份: 2022
• 资助国家: 加拿大
• 起止时间: 2022-01-01 至 2027-01-01
• 项目状态: 未结题
• 来源: https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=465631&lang=en
• 关键词: Biomarkers; Cannabis Metabolites In Breast Milk; Cannabis Metabolites In Urine; Child Development; Cohort Study; Environmental Cannabis Exposure; Executive Functioning; Home Environment; Maternal Cannabis Use; Neurodevelopment

Cannabis became legal in Canada in October 2018. It is often marketed to pregnant women as a therapy for anxiety and nausea, among other symptoms, although its use has not been proven to be safe or effective during pregnancy. Research-guided information f

大麻于2018年10月在加拿大成为法律的。它通常被销售给孕妇作为焦虑和恶心等症状的治疗，尽管它的使用尚未被证明在怀孕期间是安全或有效的。研究导向型信息服务